FACT IEC Webinar: CAR-T cells and T-cell receptor cells (TCR) cells in solid tumors
Thursday, March 30, 2023 (11am - 12pm US/Eastern)
CAR-T and TCR cell therapy has demonstrated encouraging potential for the treatment of solid tumors. During this webinar, presenters will highlight current clinical experience with CAR-T cells in solid tumors and unique considerations in manufacturing. Presenters will also discuss the need for establishing safety and efficacy quality benchmarks for CAR-T cells and TCRs.
• Matthew Frigault, MD, from Massachusetts General
• Partrow Kebriaei, MD, from the University of Texas MD Anderson Cancer Center
Registration Fees:These fees are available through 03/30/2023
|Webinar Registrants||$100.00||Webinar Registrants|
|Inspectors||$0.00||Inspector & Inspector Trainees|